SaNOtize aims to save lives and improve the quality of life for people suffering from topical infections. SaNOtize uses a nitric oxide releasing solution to prevent and cure infectious diseases that have no treatment or current treatment is ineffective or creating resistance. This platform technology has broad applicability to topical and upper respiratory infections caused by viruses, bacteria and fungi. Target indications include COVID-19, influenza, sinusitis, nail fungus, warts, acne and chronic wounds such as diabetic foot ulcers. SaNOtize’s first product, an antiviral nasal spray, is sold in certain Asia countries and is in phase III trial in North America.